Date published: 2025-10-13

1-800-457-3801

SCBT Portrait Logo
Seach Input

GPR75 Inhibitors

GPR75 inhibitors belong to a class of small molecules designed to target and modulate the activity of the GPR75 receptor. GPR75, also known as G protein-coupled receptor 75, is a protein found on the surface of certain cells in the human body, particularly in the central nervous system and peripheral tissues. This receptor is a member of the G protein-coupled receptor (GPCR) family, which plays a crucial role in cellular signaling and regulation. GPR75 has garnered significant attention in recent years due to its involvement in various physiological processes, including metabolic regulation, appetite control, and inflammation. As such, GPR75 inhibitors have emerged as valuable tools for researchers seeking to better understand the molecular mechanisms underlying these processes. GPR75 inhibitors is to selectively block or modulate the activity of the GPR75 receptor. These inhibitors are designed to interact with specific binding sites on the receptor, altering its conformation or preventing its activation by endogenous ligands. By doing so, GPR75 inhibitors can influence downstream signaling pathways and cellular responses associated with this receptor. Researchers use GPR75 inhibitors in laboratory studies to investigate the receptor's role in various physiological functions.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

NF 023

104869-31-0sc-204124
sc-204124A
10 mg
50 mg
$158.00
$617.00
1
(1)

A selective antagonist of P2X purinoceptor; can inhibit ATP-mediated GPCR signaling which may intersect with GPR75 pathways.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

An inhibitor of MEK, which in turn would inhibit the MAPK/ERK pathway, often downstream of GPCR activation, including pathways GPR75 may engage.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$182.00
$693.00
88
(1)

A ROCK inhibitor, affecting cytoskeletal rearrangements and cell motility that could be downstream of GPR75 signaling.

GW 5074

220904-83-6sc-200639
sc-200639A
5 mg
25 mg
$106.00
$417.00
10
(1)

An inhibitor of Raf-1 kinase, potentially affecting MAPK pathway activation downstream of GPR75 activation.

Chelerythrine

34316-15-9sc-507380
100 mg
$540.00
(0)

A potent inhibitor of protein kinase C, which may be activated by GPR75 signaling through Gq proteins.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

A PI3K inhibitor, which could affect the PI3K/Akt pathway, often downstream of GPCR activity, possibly including GPR75.

Suramin sodium

129-46-4sc-507209
sc-507209F
sc-507209A
sc-507209B
sc-507209C
sc-507209D
sc-507209E
50 mg
100 mg
250 mg
1 g
10 g
25 g
50 g
$149.00
$210.00
$714.00
$2550.00
$10750.00
$21410.00
$40290.00
5
(1)

A non-selective antagonist of P2 purinergic receptors, could inhibit GPCR signaling pathways that may be modulated by GPR75.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

An inhibitor of p38 MAPK, could affect inflammatory responses that GPR75 may be involved with.